June 25, 2026 Teclistamab Induction Shows Deep Responses in Newly Diagnosed Multiple Myeloma in MajesTEC-5 Trial
April 6, 2026 Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: Phase 3 IsKia Trial
March 24, 2026 PANGEA-SMM: A Novel Prediction Model for Smoldering Multiple Myeloma Progression Using Dynamic Biomarkers and Large International Cohorts
